drugset
Drugs / Tissue Stromal Vascular Fraction
last change Dec 2022 re-read 9 days ago

Tissue Stromal Vascular Fraction

also known as tSVF

Cell therapy

Developed for
osteoarthritis · tendinosis
Investigated by
Global Alliance for Regenerative Medicine · Regeneris Medical · Robert W Alexander, MD

Trials 1

today NCT03090672 · not/applicable
20172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT03090672 Mar 2017 → Aug 2021 osteoarthritis, tendinosis Robert W Alexander, MD Unknown No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Tissue Stromal Vascular Fraction “Procedure: Tissue Stromal Vascular Fraction” NCT03090672 ↗
Known as tSVF “Stromal Vascular Fraction tSVF + Platelet Rich Plasma (PRP) concentrate” NCT03090672 ↗
Modality Cell therapy “use of stem/stromal cells (either from adipose or marrow)” NCT03090672 ↗